Also STAT3 is overexpressed in ovarian cancer compared with normal or benign ovarian tumour tissue, and its expression was significantly higher in FIGO stage III/IV compared with stage I/II (Min and Wei-hong, 2009). Here, STAT3 is linked to ovarian benign neoplasm.